Key result
Blood flow restriction training improves cognition and sleep quality vs usual care in MS.
Why the study?
Cognitive impairment and sleep disturbances are prevalent in middle-aged MS patients, but tolerance to high-intensity exercise is often limited, making blood flow restriction training a potential alternative.
Does blood flow restriction training improve cognitive performance and sleep quality in middle-aged adults with relapsing-remitting multiple sclerosis?
RCT (n=65)
outcome assessors and data analysts blinded; participants and physiotherapists not blinded after assignment
computerized randomization with 1:1 allocation ratio and allocation concealment using opaque sealed envelopes
No
Does blood flow restriction training improve cognitive performance and sleep quality in middle-aged adults with relapsing-remitting multiple sclerosis?
Effect estimate: Cohen's d 0.55 to 1.07
Absolute Event Rate: 33.06% vs 25.97%
p-value: p < 0.05 for group*time interactions
A 12-week blood flow restriction training program improves cognitive performance and sleep quality in middle-aged adults with relapsing-remitting multiple sclerosis.
No takes yet. Share an insight, caveat, or question.
Supports BFR training for cognitive/sleep gains in RRMS; extends prior exercise evidence with RCT data.
Background/Objectives: Cognitive impairment and sleep disturbances are highly prevalent in individuals with multiple sclerosis (MS), particularly during middle age, and negatively affect functional independence and quality of life. Although physical exercise has demonstrated cognitive and sleep-related benefits in MS, tolerance to high-intensity training is often limited. Blood flow restriction (BFR) training, which combines low-load resistance exercise with partial vascular occlusion, has emerged as a feasible alternative. This study aimed to evaluate the effects of a 12-week BFR training program on performance in specific cognitive domains and sleep quality in middle-aged adults with MS. Methods: A randomized controlled trial was conducted in 65 adults with relapsing–remitting multiple sclerosis (RRMS) aged 40–65 years and an Expanded Disability Status Scale score below 7. Participants were randomly assigned to a BFR training group or a usual-care control group. The intervention consisted of supervised low-load resistance training with BFR performed twice weekly for 12 weeks. Outcomes assessed before and after the intervention included processing speed (Symbol Digit Modalities Test), executive function (Trail Making Test A and B), verbal fluency (Isaacs Set Test), and self-reported sleep quality (Pittsburgh Sleep Quality Index). Results: Compared with controls, participants in the BFR group showed significant improvements in specific cognitive domains, including processing speed, executive function, and verbal fluency. Significant reductions were also observed in self-reported global sleep disturbance and daytime dysfunction. No adverse events were reported. Conclusions: A 12-week BFR training program improved performance in key cognitive domains and self-reported sleep quality in middle-aged adults with MS, supporting its feasibility and potential clinical relevance as an exercise-based intervention.
Cano-Sánchez et al. (2026) conducted an RCT in Middle-aged adults (40-65 years) with relapsing–remitting multiple sclerosis and Expanded Disability Status Scale score below 7 (n=65). Blood Flow Restriction (BFR) training vs. Usual care control group maintaining routine medical treatment without new exercise program was evaluated on Cognitive performance (processing speed via Symbol Digit Modalities Test, executive function via Trail Making Test A and B, verbal fluency via Isaacs Set Test) and self-reported sleep quality (Pittsburgh Sleep Quality Index) (Cohen's d 0.55 to 1.07, p=p < 0.05 for group*time interactions). Blood flow restriction training for 12 weeks improved processing speed (SDMT increased from 25.19 to 33.06, p=0.030), executive function, verbal fluency, and self-reported sleep quality compared to usual care in middle-aged adults with relapsing–remitting multiple sclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: